Tracking Systemic Atherosclerosis Across Vascular Beds

19 concepts12 papers1 proposal

Medical intuition often treats vascular diseases as localized plumbing problems. A blockage in a coronary artery causes a heart attack; a clot in a carotid artery causes a stroke; narrowing in the legs causes peripheral arterial disease.

However, a growing body of research demonstrates that these conditions are localized manifestations of a single, systemic pathology. Because every blood vessel in the body shares a common endothelium, experiences the same circulating inflammatory signals, and responds to the same systemic stressors—like hypertension and diabetes—the health of one vascular bed directly mirrors the health of another.

By treating the vascular system as an interconnected network, researchers have uncovered how accessible peripheral vessels and systemic blood markers can serve as diagnostic windows into otherwise silent, critical diseases in central organs.

Peripheral Windows into Central Vessels

Why can we look at an artery in the wrist or leg to understand the state of the heart? The answer lies in the shared environmental exposure of the vascular wall. If systemic factors like aging, smoking, or metabolic stress are causing plaque accumulation in high-risk areas like the coronary arteries, those same forces are operating throughout the entire circulatory system.

[Systemic Stressors: Hypertension, Diabetes, Smoking]
                       │
                       ▼
         ┌─────────────┴─────────────┐
         ▼                           ▼
┌─────────────────┐         ┌─────────────────┐
│ Peripheral Beds │         │  Central Beds   │
│ (Radial, Legs)  │ ◄─────► │ (Coronary, CNS) │
└─────────────────┘         └─────────────────┘
  [Easy to Image]             [Silent Danger]

This correlation allows accessible peripheral arteries to function as clinical proxies for central cardiovascular risk. For instance, Yan et al. utilized high-resolution optical coherence tomography to map plaque distribution in the radial artery, demonstrating that the presence of radial artery atherosclerosis serves as a reliable indicator for the severity of multi-vessel coronary artery disease (Mapping the distribution of radial artery atherosclerosis by optical coherence tomography).

Similarly, the lower extremities provide an early warning system for cerebrovascular danger. Yun et al. discovered that 14% of patients with severe peripheral arterial disease (PAD) in their lower limbs harbored "silent," asymptomatic, but critical carotid artery stenosis (Prevalence of Asymptomatic Critical Carotid Artery Stenosis in Korean Patients with Chronic Atherosclerotic Lower Extremity Ischemia: Is a Screening Carotid Duplex Ultrasonography Worthwhile?).

This systemic decay is also functional, not just structural. Liu et al. used power ultrasound to show that as coronary heart disease and heart failure progress, the ability of peripheral blood vessels in the limbs to dilate declines in tandem (The change of vascular endothelium in coronary heart disease). The endothelium fails as a unified system.

Circulating Signatures of Plaque Burden

Because the entire vascular network is bathed in the same bloodstream, systemic cellular and molecular markers can index the total burden of multi-vessel disease.

When plaques become widespread and unstable, they trigger systemic platelet activation. Qiu et al. demonstrated that Mean Platelet Volume (MPV)—a simple measure of platelet size and reactivity—directly correlates with the Gensini score, which quantifies coronary artery stenosis severity (Correlation between Mean Platelet Volume and Gensini Score in Patients with Coronary Heart Disease in Different Diabetic States). Larger, more active platelets reflect the transition from a localized plaque to a systemic, multi-vessel inflammatory state, a relationship that intensifies in diabetic environments.

At the molecular level, specific regulatory pathways operate systemically to protect or compromise arterial health. The long noncoding RNA NEXN-AS1 and its neighboring protein-coding gene NEXN act as a molecular shield against vascular inflammation. As shown by Hu et al., a systemic drop in these vascular-associated proteins correlates tightly with the presence and severity of coronary artery disease, offering a potential blood-based metric for widespread arterial decay (Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN).

The Cardio-Cerebrovascular Axis

The clinical consequence of this shared pathology is a powerful cross-talk between the heart and the brain. A patient diagnosed with disease in one bed is highly likely to harbor silent disease in the other.

Evaluating large patient cohorts reveals the predictability of this axis:

These links confirm that a clinical event in either the heart or brain should not be viewed in isolation, but rather as a symptom of a systemic cardio-cerebrovascular syndrome.

Micro-scale Brain Lesions as Systemic Indicators

The systemic nature of vascular disease extends down to the microscopic vessels of the central nervous system. Small vessel diseases in the brain—manifested as cortical microinfarcts (CMIs), cerebral microbleeds (CMBs), and lacunar strokes—are not merely isolated neurological events; they are downstream consequences of macro-scale systemic failure.

┌──────────────────────────────┐
│ Macro-Vascular Atherosclerosis│ (Carotid & Peripheral Disease)
└──────────────┬───────────────┘
               │
               ▼
┌──────────────────────────────┐
│ Global Perfusion Failure     │ (Reduced Cerebral Blood Flow)
└──────────────┬───────────────┘
               │
               ▼
┌──────────────────────────────┐
│ Micro-Vascular Brain Lesions │ (CMIs, CMBs, Lacunar Strokes)
└──────────────────────────────┘

Cortical microinfarcts, for example, are tiny ischemic cellular necrosis zones. Rather than being caused by localized micro-clots, the authors of a study on memory clinic patients (Ferro et al.) showed that CMIs are strongly associated with a global reduction in cerebral blood flow throughout the brain's anterior circulation (Cortical microinfarcts in memory clinic patients are associated with reduced cerebral perfusion).

This global perfusion deficit is frequently driven by upstream, large-vessel disease. Using high-resolution 7T MRI, Zwartbol et al. confirmed that the presence of multiple CMIs is intrinsically linked to extracranial atherosclerosis in the carotid and peripheral circulation (Cortical cerebral microinfarcts on 7T MRI: Risk factors, neuroimaging correlates and cognitive functioning – The Medea-7T study).

Similarly, acute lacunar strokes and cerebral microbleeds serve as structural markers of underlying small vessel fragility. Arba et al. demonstrated that systemic baseline metrics, such as elevated systolic blood pressure and pre-existing lacunes, dictate the emergence of new lacunar infarcts (Improving Clinical Detection of Acute Lacunar Stroke).

When these micro-markers appear, they present a clinical paradox: they signal an increased relative risk of intracranial hemorrhage, complicating the use of standard antithrombotic therapies. However, large-scale pooled analyses by Wilson et al. (Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies) and Prats-Sánchez et al. (Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds) demonstrate that despite local vascular fragility, the absolute risk of recurrent ischemic stroke remains higher.

Consequently, systemic therapies like statins still provide a net clinical benefit. This underscores the ultimate reality of the condition: treating the systemic, macro-vascular drivers of disease remains the most effective way to protect the fragile, microscopic vessels of the brain.

History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_multi_vessel_disease_markers_666c80c0,
  title = {multi-vessel disease markers},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/multi-vessel-disease-markers/rdr_666c80c07b5a44d1ab722255b000dfd6},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}

This exact version (version 1, frozen text):

@misc{lacuna_multi_vessel_disease_markers_666c80c0_v1,
  title = {multi-vessel disease markers},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/multi-vessel-disease-markers/rdr_666c80c07b5a44d1ab722255b000dfd6/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake